BlackRock Investment Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.63M Buy
156,147
+31,107
+25% +$519K ﹤0.01% 2031
2016
Q3
$2.19M Buy
125,040
+468
+0.4% +$7.59K ﹤0.01% 2083
2016
Q2
$1.79M Buy
124,572
+14,686
+13% +$184K ﹤0.01% 2195
2016
Q1
$1.35M Sell
109,886
-449
-0.4% -$4.96K ﹤0.01% 2275
2015
Q4
$1.34M Sell
110,335
-696
-0.6% -$8.57K ﹤0.01% 2375
2015
Q3
$1.46M Buy
111,031
+854
+0.8% +$12.9K ﹤0.01% 2303
2015
Q2
$1.81M Buy
110,177
+13,871
+14% +$230K ﹤0.01% 2323
2015
Q1
$1.71M Buy
96,306
+1,255
+1% +$23.3K ﹤0.01% 2143
2014
Q4
$1.81M Buy
95,051
+12,554
+15% +$213K ﹤0.01% 2107
2014
Q3
$1.13M Buy
82,497
+569
+0.7% +$8.12K ﹤0.01% 2437
2014
Q2
$1.34M Sell
81,928
-2,003
-2% -$29K ﹤0.01% 2385
2014
Q1
$1.32M Buy
83,931
+810
+1% +$13.2K ﹤0.01% 2315
2013
Q4
$1.43M Sell
83,121
-1,703
-2% -$26.2K ﹤0.01% 2257
2013
Q3
$1.12M Buy
84,824
+279
+0.3% +$3.29K ﹤0.01% 2365
2013
Q2
$954K Buy
+84,545
New +$900K ﹤0.01% 2392

Other funds holding ANGO

BlackRock Investment Management's ANGO Position: Q4 2016 in Review

BlackRock Investment Management increased its AngioDynamics (ANGO) stake by 25% in Q4 2016, buying an estimated $519K and bringing the position to 156,147 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2031.

BlackRock Investment Management first reported a position in ANGO in Q2 2013 and has held it in 15 quarters since. 151 funds tracked by Wall St. Rank hold ANGO as of Q4 2016.

  • BlackRock Investment Management held 156,147 shares of AngioDynamics worth $2.63M as of Q4 2016.
  • BlackRock Investment Management bought 31,107 AngioDynamics shares in Q4 2016, an estimated $519K.
  • AngioDynamics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2031 holding.
  • BlackRock Investment Management first reported a position in AngioDynamics in Q2 2013 and has held it in 15 quarters since.
  • 151 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.